Philips Gets FDA Emergency Use Approval for Monitors, Displays in US
By Adriano Marchese
Koninklijke Philips NV said Tuesday that it has received
emergency use authorization for its patient monitors and active
displays during the pandemic from the U.S. Food and Drug
The technology company said the emergency use authorization will
be for its IntelliVue Patient Monitors MX750 and MX850 as well as
its IntelliVue Active Displays AD75 and AD85.
Philips said that the emergency use authorization allows the
company to begin delivering the new remote patient-monitoring
product to hospitals in the U.S.
The company added that it is "significantly increasing" its
patient-monitor production to address the demand for more
Write to Adriano Marchese at firstname.lastname@example.org
(END) Dow Jones Newswires
June 02, 2020 08:34 ET (12:34 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.